Nautilus Biotechnology (NAUT) Interest Expenses (2022 - 2026)

Nautilus Biotechnology has disclosed Interest Expenses across 5 years of filings, most recently posting $15000.0 for Q1 2026.

• Interest Expenses for Q1 2026 came in at $15000.0, changed N/A year-over-year; the trailing twelve-month figure through Mar 2026 was $47000.0 (down 44.05% YoY), and the FY2025 annual result was $32000.0, down 61.9% from the prior year.
• Interest Expenses came in at $15000.0 for Q1 2026 at Nautilus Biotechnology, up from $11000.0 in the prior quarter.
• In the past five years, Interest Expenses ranged from a high of $56000.0 in Q4 2023 to a low of $3000.0 in Q1 2023.
• The 5-year median for Interest Expenses is $15000.0 (2026), against an average of $19000.0.
• Across the five-year window, Interest Expenses surged 35.71% in 2024 and slumped 75.56% in 2025, its largest moves.
• Nautilus Biotechnology's Interest Expenses stood at $5000.0 in 2022, then jumped by 1020.0% to $56000.0 in 2023, then slipped by 19.64% to $45000.0 in 2024, then plunged by 75.56% to $11000.0 in 2025, then jumped by 36.36% to $15000.0 in 2026.
• The last three Interest Expenses figures came in at $15000.0 (Q1 2026), $11000.0 (Q4 2025), and $5000.0 (Q3 2025), per Business Quant data.